摘要
目的:制备甘草酸二铵-壳聚糖纳米粒(DG-CS NPs),评价其制剂学性质及对溃疡性结肠炎的治疗效果。方法:喷雾干燥法制备DG-CS NPs,正交设计法优化;考察纳米粒的形态、粒径分布及体外释放特征。硫酸葡聚糖诱导溃疡性结肠炎(UC)模型小鼠,以疾病活动指数法评价DG-CS NPs的治疗效果。结果:DG-CS NPs大小在300-600 nm,载药量为(51.25±1.75)%。DG-CS NPs的药物释放受环境pH的影响,对UC具有显著的治疗与改善效果。结论:喷雾干燥法制得DG-CS NPs对UC模型小鼠具有治疗作用。
Objective: To prepare the diammonium glycyrrhizinate-loaded chitosan nanoparticles(DG-CS NPs),and evaluate its pharmaceutical properties and pharmacodynamic effects on ulcerative colitis(UC).Method: DG-CS NPs were prepared by spray drying method and optimized by orthogonal design.The morphology,size and in vitro release of DG-CS NPs were investigated.The therapeutic effects of DG-CS NPs on UC mice induced by dextran sulfate were evaluated preliminarily through disease active index method.Result: The size of DG-CS NPs with loading capacity about(51.25±1.75)% was in the range of 300-600 nm.The release of DG-CS NPs was associated with environmental pH value and displayed significant therapeutic and preventive effects on UC.Conclusion: DG-CS NPs prepared by spray drying method showed efficacy on UC mice.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2010年第16期2138-2141,共4页
China Journal of Chinese Materia Medica
基金
科技部国际科技合作项目(2009DFA31330)
国家"重大新药创制"科技重大专项(2009ZX09502-009)
关键词
甘草酸二铵
壳聚糖
纳米粒
溃疡性结肠炎
diammonium glycyrrhizinate
chitosan
nanoparticles
ulcerative colitis